M&A Corner
Altamira Therapeutics Prices ~$5M Public Offering of Shares11 Jul 2023
Altamira Therapeutics has priced a public offering of approximately $5 million in shares. The offering includes 11.1 million shares or... Continue Reading
|
IGC Pharma Announces a $3 Million Private Placement of its Common Stock11 Jul 2023
IGC Pharma has announced a strategic investment from four investment funds managed by Bradbury Asset Management, totaling approximately $3 million... Continue Reading
|
Allegheny Health Network to Support Israeli Health Startups with Israel Innovation Authority Partnership11 Jul 2023
Allegheny Health Network (AHN) and the Israel Innovation Authority have signed a memorandum of understanding to establish a partnership supporting... Continue Reading
|
Floyd Mayweather Jr., Enhance Health Partner to Expand Healthcare Access.11 Jul 2023
Health insurance brokerage and care navigation platform, Enhance Health, has formed an exclusive partnership with boxing champion Floyd Mayweather Jr.... Continue Reading
|
Crystal Pharmatech Recognized as “Best Partner” by Allorion Therapeutics for Excellent Services11 Jul 2023
Crystal Pharmatech has received recognition from Allorion Therapeutics for its exceptional services in supporting a First-in-Human (FIH) study. Allorion Therapeutics,... Continue Reading
|
Abeona Therapeutics Raises $25M.11 Jul 2023
Abeona Therapeutics has raised $25 million through an at-the-market offering from existing investors. The company issued 3.28 million shares and... Continue Reading
|
Gilead and Teva Prevail in Potentially $3.6B ‘Pay-to-Delay’ Lawsuit11 Jul 2023
Gilead and Teva Pharmaceuticals have been cleared of allegations in a lawsuit claiming an illegal agreement that led to inflated... Continue Reading
|
Labcorp Completes Spin-off of Fortrea11 Jul 2023
LabCorp, a global leader in laboratory services, has successfully completed the spin-off of Fortrea, an independent Contract Research Organization specializing... Continue Reading
|
Lilly to Buy European ADC Player Emergence Therapeutics03 Jul 2023
Eli Lilly has acquired European startup Emergence Therapeutics, a biotech focused on developing antibody-drug conjugates (ADCs) for cancers with high... Continue Reading
|
Baudax Bio Acquires TeraImmune, Inc.03 Jul 2023
Baudax Bio, a pharmaceutical company focused on acute care, has acquired TeraImmune, a biotechnology company specializing in Treg-based cell therapies... Continue Reading
|